199 related articles for article (PubMed ID: 10844110)
1. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].
Cracowski JL; Stanke-Labesque F; Devillier P; Chavanon O; Hunt M; Souvignet C; Bessard G
Eur J Pharmacol; 2000 May; 397(1):161-8. PubMed ID: 10844110
[TBL] [Abstract][Full Text] [Related]
2. Isoprostaglandin E2 type-III (8-iso-prostaglandin E2) evoked contractions in the human internal mammary artery.
Cracowski JL; Devillier P; Chavanon O; Sietchiping-Nzepa FA; Stanke-Labesque F; Bessard G
Life Sci; 2001 Apr; 68(21):2405-13. PubMed ID: 11350011
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.
Stanke-Labesque F; Devillier P; Bedouch P; Cracowski JL; Chavanon O; Bessard G
Cardiovasc Res; 2000 Aug; 47(2):376-83. PubMed ID: 10946074
[TBL] [Abstract][Full Text] [Related]
4. Vasoconstrictor effects of iso-prostaglandin F2alpha type-III (8-iso-prostaglandin F2alpha) on human saphenous veins.
Gardan B; Cracowski JL; Sessa C; Hunt M; Stanke-Labesque F; Devillier P; Bessard G
J Cardiovasc Pharmacol; 2000 May; 35(5):729-34. PubMed ID: 10813374
[TBL] [Abstract][Full Text] [Related]
5. Characterization of prostanoid receptors mediating actions of the isoprostanes, 8-iso-PGE(2) and 8-iso-PGF(2alpha), in some isolated smooth muscle preparations.
Sametz W; Hennerbichler S; Glaser S; Wintersteiger R; Juan H
Br J Pharmacol; 2000 Aug; 130(8):1903-10. PubMed ID: 10952681
[TBL] [Abstract][Full Text] [Related]
6. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
7. Glibenclamide inhibits thromboxane A2-induced contraction in human internal mammary artery and saphenous vein.
Stanke F; Cracowski JL; Chavanon O; Magne JL; Blin D; Bessard G; Devillier P
Eur J Pharmacol; 1998 Jan; 341(1):65-71. PubMed ID: 9489857
[TBL] [Abstract][Full Text] [Related]
8. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
He GW; Yang CQ
J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi.
Barchasz E; Naline E; Molimard M; Moreau J; Georges O; Emonds-Alt X; Advenier C
Eur J Pharmacol; 1999 Aug; 379(1):87-95. PubMed ID: 10499376
[TBL] [Abstract][Full Text] [Related]
11. Response of rat thoracic aorta to F(2)-isoprostane metabolites.
Cracowski JL; Camus L; Durand T; Devillier P; Guy A; Hardy G; Stanke-Labesque F; Rossi JC; Bessard G
J Cardiovasc Pharmacol; 2002 Mar; 39(3):396-403. PubMed ID: 11862119
[TBL] [Abstract][Full Text] [Related]
12. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
13. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
14. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
Janssen LJ; Tazzeo T
J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
[TBL] [Abstract][Full Text] [Related]
15. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
[TBL] [Abstract][Full Text] [Related]
16. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.
Daray FM; Minvielle AI; Puppo S; Rothlin RP
Eur J Pharmacol; 2004 Sep; 499(1-2):189-95. PubMed ID: 15363966
[TBL] [Abstract][Full Text] [Related]
17. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
Kawikova I; Barnes PJ; Takahashi T; Tadjkarimi S; Yacoub MH; Belvisi MG
Am J Respir Crit Care Med; 1996 Feb; 153(2):590-6. PubMed ID: 8564103
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive responses of U46619, PGF2alpha, latanoprost, and travoprost in isolated porcine ciliary arteries.
Vysniauskiene I; Allemann R; Flammer J; Haefliger IO
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):295-8. PubMed ID: 16384976
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of vapiprost on contractile responses of isolated dog renal arteries to thromboxane A2 analogue, U46619.
Sakanashi M; Matsuzaki T; Noguchi K; Nakasone J; Itomine T; Uza M; Toyama F; Higuchi M
Gen Pharmacol; 1994 Jul; 25(4):617-22. PubMed ID: 7958719
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
